Welcome to our dedicated page for Sherwin-Williams SEC filings (Ticker: SHW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sherwin-Williams Company (NYSE: SHW) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its paint and coatings business, capital structure and governance. As a registrant under the Exchange Act, Sherwin-Williams discloses information on its common stock, which is listed on the New York Stock Exchange under the symbol SHW, and reports on matters affecting shareholders and creditors.
On this page, you can review current and historical SEC filings for Sherwin-Williams, including Form 10‑K annual reports and Form 10‑Q quarterly reports, which describe its operations in the Paint Stores Group, Consumer Brands Group and Performance Coatings Group, along with risk factors, segment information and notes on brands such as Sherwin-Williams, Valspar, HGTV HOME by Sherwin-Williams, Dutch Boy, Krylon, Minwax, Thompson's WaterSeal and Cabot. These core filings explain how the company organizes its global paint and coatings activities and discuss markets such as construction, industrial, packaging and transportation.
The company also uses Form 8‑K to report material events. Recent examples include credit and term loan agreements, amendments to revolving credit facilities, senior notes offerings, the acquisition of Suvinil Coatings S.A. in Brazil, quarterly earnings releases furnished under Item 2.02, and leadership changes such as the planned transition to a new Chief Financial Officer. Filings under Items 1.01, 2.03, 5.02 and 8.01 provide detail on new obligations, financing terms, executive appointments and completed transactions.
In addition, investors can monitor capital structure and potential insider-related information through exhibits and references to proxy statements that describe executive compensation and change‑in‑control severance agreements. This page surfaces new filings as they appear on EDGAR and pairs them with AI-generated summaries that highlight key terms, affected segments and financial implications, helping readers quickly understand complex credit agreements, acquisition disclosures and other technical documents without reading every page.
Sherwin-Williams (SHW) disclosed an officer stock option grant in a Form 4. The filing reports an award of 6,270 employee stock options on October 20, 2025 at an exercise price of $331.37 per share. The officer is identified as Pres. & GM, Glob. Supply Chain.
The options were granted under the 2025 Equity and Incentive Compensation Plan and vest annually in three substantially equal installments commencing October 20, 2026. The options expire on October 19, 2035. Following the reported transaction, 6,270 derivative securities were beneficially owned, with direct ownership indicated.
Sherwin-Williams (SHW) reported an insider equity grant: its SVP–CHRO received 6,060 employee stock options with an exercise price of $331.37 per share on October 20, 2025, under the 2025 Equity and Incentive Compensation Plan.
The options vest in three substantially equal annual installments starting October 20, 2026, and expire on October 19, 2035. This is a standard compensation award that sets the right to buy common stock at a fixed price over time as service-based vesting conditions are met.
Sherwin-Williams (SHW) disclosed a routine insider equity grant. The company’s President, Consumer Brands Group, reported the award of 4,595 employee stock options on October 20, 2025 with an exercise price of $331.37 and expiration on October 19, 2035.
The options vest in three substantially equal annual installments beginning October 20, 2026, under the 2025 Equity and Incentive Compensation Plan. Following this grant, the reporting person beneficially owns 4,595 derivative securities, held directly. This filing reflects standard compensation rather than an open‑market transaction.
Sherwin-Williams (SHW) reported an insider equity award. The company’s SVP – Corp Strategy & Devel. received an employee stock option grant for 3,340 shares at an exercise price of $331.37 on 10/20/2025, recorded as an acquisition. The options expire on 10/19/2035 and were reported as Direct ownership.
The award vests annually in three substantially equal installments commencing 10/20/2026, pursuant to the 2025 Equity and Incentive Compensation Plan. The derivative security price was reported as $0.
Sherwin-Williams (SHW) reported an insider equity award on Form 4. An officer (SVP – IR & Corp. Comm.) was granted an employee stock option to purchase 2,510 shares at an exercise price of $331.37 on October 20, 2025. The options expire on October 19, 2035 and vest annually in three substantially equal installments commencing October 20, 2026, subject to vesting conditions. Following the grant, 2,510 derivative securities were beneficially owned directly.
Sherwin-Williams (SHW) reported an insider equity grant for its SVP – Enterprise Finance & CAO. A Form 4 discloses the award of 2,300 employee stock options at an exercise price of $331.37 per share on 10/20/2025.
The options were granted under the 2025 Equity and Incentive Compensation Plan and vest annually in three substantially equal installments beginning 10/20/2026, subject to vesting conditions. The options expire on 10/19/2035. Following the transaction, the reporting person beneficially owned 2,300 derivative securities, held directly.
Thomas Williams, a company director at Sherwin-Williams (SHW), received deferred equity under the 2005 Director Deferred Fee Plan on 10/03/2025. The filing reports 1,813 deferred stock units and common shares credited to his account, calculated using a weighted average share price of $343.81 to determine unit amounts. The deferred stock units are payable only in stock, generally after the director leaves service, and include units credited via a dividend reinvestment feature. The filing also notes ownership following the transaction of 953.23 (reported as beneficially owned) under an indirect form, and that 1,147 RSUs plus 666 shares comprise the 1,813 figure.
Sherwin-Williams Co. (SHW) director Michael H. Thaman reported changes in his beneficial ownership on 10/03/2025 in a Form 4 filing. The filing shows an acquisition of deferred stock units under the 2005 Director Deferred Fee Plan and a disposition of 7,553 common stock-related holdings. The filing states 98.17 deferred stock units were credited using a weighted average share price of $343.81, and it lists 5,370.62 as the amount of securities beneficially owned following the transaction (identified as indirect ownership). The disposition entry lists 7,553 which the filing explains consists of 1,150 restricted stock units and 6,403 shares of common stock. The deferred units are payable solely in stock and generally become payable after the reporting person separates from service as a director.
Robert J. Gamgort, a director of Sherwin-Williams Co. (SHW), reported changes in his beneficial ownership on 10/03/2025. He acquired 98.17 deferred stock units under the 2005 Director Deferred Fee Plan at a weighted average price of $343.81, and disposed of 517 restricted stock units (RSUs). After the reported transactions he beneficially owns 281.71 deferred stock units held indirectly; the deferred units are payable in shares following separation from service.
Kerrii B. Anderson, a director of Sherwin-Williams (SHW), reported changes in beneficial ownership on 10/03/2025. The filing shows the director acquired deferred stock units under the 2005 Director Deferred Fee Plan equal to 29.09 units at a weighted average price of $343.81 per share; those deferred units are payable in stock, generally after separation from service. The report also shows a disposition of 5,261 common stock-related instruments, comprised of 1,150 restricted stock units (RSUs) and 4,111 shares of common stock. Following the transaction, the reporting person beneficially owned 979.69 deferred stock units indirectly.